• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, February 4, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

George Mason University Health College continues NSF funded study of coronaviruses

Bioengineer by Bioengineer
May 6, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

National Science Foundation grant enables Dr. Amira Roess to continue to investigate Middle East Respiratory Syndrome (MERS-CoV2) and related coronaviruses

IMAGE

Credit: George Mason University

The College of Health and Human Services at George Mason University received a grant from the National Science Foundation (NSF) to study the emergence and spread of coronaviruses such as COVID-19, Middle East Respiratory Syndrome (MERS-CoV2), and severe acute respiratory syndrome (SARS). Dr. Amira Roess, who joined Mason’s faculty in the fall of 2019 as a professor in the Department of Global and Community Health, is the principal investigator on the grant. Roess studies the spread of MERS-CoV2, a novel coronavirus, between wildlife, camels and humans in East Africa.

The original $2.45million grant for this research was awarded to Roess when she was at George Washington University (GWU) in 2018 (Grant number 1816064). Roess will continue to oversee this multidisciplinary collaboration between colleagues at American University, Charité – Universitätsmedizin Berlin, GWU, University of Georgia, Addis Ababa Science and Technology University, and Dilla University on this multi-year research project.

Funding from this grant allows for continued development of models that predict coronavirus emergence and transmission by incorporating environmental, social, behavioral, and cultural factors.

“Bringing this NSF grant to Mason will allow us to continue doing the analysis and monitoring required to understand coronavirus epidemiology, including why some strains are more contagious than others and why some have higher fatality rates,” says Roess, “our research seeks to better understand the role of antibodies and that will allow us to develop public health responses to lower infection risk.” Her ongoing coronavirus research continues to help inform public health practices related to COVID-19 at the federal, state, and local level.

“It has never been more critical to advance this research as we experience the global implications of the COVID-19 pandemic. NSF support will allow the College to understand and disseminate life-saving knowledge of coronaviruses and develop public health protocols to fight COVID-19,” says Dr. Germaine Louis, professor and dean of the College of Health and Human Services.

Coronaviruses are a family of related viruses that mostly infect birds and mammals and are known to infect humans. When present in humans, the viruses can cause mild infections in the upper respiratory tract as well as more serious lower respiratory tract infections. Prior to the COVID-19 outbreak, the number of coronaviruses cases reported globally was low (SARS-CoV 8,400; MERS-CoV 2,500, COVID-19 1.4 million*), with a high case fatality rate (SARS-CoV 9.6%; MERS-CoV 34%, COVID-19 1.38%-3.4%*).

###

* As of April 9, 2020

About George Mason University

George Mason University is Virginia’s largest and most diverse public research university. Located near Washington, D.C., Mason enrolls 38,000 students from 130 countries and all 50 states. Mason has grown rapidly over the past half-century and is recognized for its innovation and entrepreneurship, remarkable diversity and commitment to accessibility. For more information, visit https://www2.gmu.edu/.

About the College of Health and Human Services

George Mason University’s College of Health and Human Services prepares students to become leaders and shape the public’s health through academic excellence, research of consequence and interprofessional practice. The College enrolls 1,917 undergraduate students and 950 graduate students in its nationally recognized offerings, including: 5 undergraduate degrees, 12 graduate degrees, and 11 certificate programs. The College is transitioning to a college public health in the near future. For more information, visit https://chhs.gmu.edu/.

Media Contact
Michelle Thompson
[email protected]

Original Source

https://chhs.gmu.edu/news/585436

Tags: Disease in the Developing WorldEpidemiologyInfectious/Emerging DiseasesMedicine/HealthVirologyZoology/Veterinary Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Scientists Create a “Rosetta Stone” to Unlock the Secrets of Chronic Pain Neurons

Scientists Create a “Rosetta Stone” to Unlock the Secrets of Chronic Pain Neurons

February 4, 2026

Scientists Identify Brain Network Linked to Parkinson’s Disease

February 4, 2026

Case Western Reserve Professor Develops Innovative Card Deck to Help Kids Manage Stress Effectively

February 4, 2026

Exploring Patient-Centered Care in Northwest Ethiopia

February 4, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    158 shares
    Share 63 Tweet 40
  • Robotic Ureteral Reconstruction: A Novel Approach

    81 shares
    Share 32 Tweet 20
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

How a Heart Drug Could Pave the Way for Targeted Lymphoma Treatments

Multifunctional Extracellular Vesicles: Pioneering Advances in Lung Cancer Drug Delivery

Scientists Identify Oral Compound That Advances the Body’s Internal Clock

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.